Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Neurology > 2026 Vol. 1 > No. 1 > 100012
Next Article Previous Article
COMMENTARY   Open Access     Cite

The NLRP3 inflammasome in Parkinson disease: Breaking a self-reinforcing neuroimmune circuit

  • 1.

    Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

More Information
The Innovation Neurology  1(1),  https://doi.org/10.59717/j.xinn-tine.2026.100012  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Liu, K., He, Z., Zhang, L. et al. (2026). The NLRP3–α-Synuclein Circuit: A Core Driver and Therapeutic Target in Parkinson's Disease. J. Inflamm. Res. 19:1−17. DOI:10.2147/JIR.S597280

    View in Article CrossRef Google Scholar

    [2] Luque, M., Matic, M., Heras-Garvin, A. et al. (2026). Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism. J. Neuroinflammation 23:76. DOI:10.1186/s12974-026-03716-3

    View in Article CrossRef Google Scholar

    [3] Huang, P., Zhang, Z., Zhang, P. et al. (2024). TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells. Mol. Neurobiol. 61:2590−2605. DOI:10.1007/s12035-023-03713-0

    View in Article CrossRef Google Scholar

    [4] Miao, Q., Wang, T., Wang, H. et al. (2025). Loss of DJ-1 alleviates microglia-mediated neuroinflammation in Parkinson’s disease via autophagy-lysosomal degradation of NLRP3. Front. Immunol. 16. DOI:10.3389/fimmu.2025.1656729.

    View in Article Google Scholar

    [5] Abdelaziz, A. M., Rasheed, N. O. A., Zaki, H. F. et al. (2025). Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through targeting the NLRP3/Nurr1/GSK-3β/SIRT3 pathway and autophagy modulation in rotenone-lesioned rats. Int. Immunopharmacol. 146:113839. DOI:10.1016/j.intimp.2024.113839

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    An C., Zhong M., Fang Z., et al. (2026). The NLRP3 inflammasome in Parkinson disease: Breaking a self-reinforcing neuroimmune circuit. The Innovation Neurology 1:100012. https://doi.org/10.59717/j.xinn-tine.2026.100012
    An C., Zhong M., Fang Z., et al. (2026). The NLRP3 inflammasome in Parkinson disease: Breaking a self-reinforcing neuroimmune circuit. The Innovation Neurology 1:100012. https://doi.org/10.59717/j.xinn-tine.2026.100012

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(202) PDF downloads(120)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Published articles are licensed under CC BY with copyright retained by the authors.
    All contents on this site: Copyright © 2026 INNOVATION PRESS. All rights are reserved.